• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Univar Solutions Selected as Ingredion Pharma Solutions Distributor in United States and Canada

    2/24/26 12:30:00 PM ET
    $INGR
    Packaged Foods
    Consumer Staples
    Get the next $INGR alert in real time by email

    Pharmaceutical manufacturers will benefit from deep expertise and an extensive distribution network paired with Ingredion's functional excipients

    DOWNERS GROVE, Ill., Feb. 24, 2026 /CNW/ -- Univar Solutions LLC ("Univar Solutions" or "the Company"), a leading global solutions provider to users of specialty ingredients and chemicals, today announced that its Ingredients +  Specialties from Univar Solutions division has been appointed as a distributor for Ingredion Pharma Solutions, part of Ingredion Incorporated (NYSE:INGR). The agreement includes distribution of Ingredion's global pharmaceuticals portfolio and positions the Company as the exclusive distributor of pharmaceutical starches in the United States and Canada. This strategic partnership enables Ingredients + Specialties to further diversify and strengthen its pharmaceutical and nutraceutical ingredients portfolios with a broad range of functional excipients, including direct compression and wet granulation binders, fillers for tablets and capsules, superdisintegrants, lubricants, emulsion for encapsulation, and gelatin replacements for vegetarian softgel formulations.

    Ingredients + Specialties from Univar Solutions brings the best products, people, and results to customers and specialist suppliers looking to power modern life. By combining science, innovation, and deep knowledge with a leading portfolio of specialties, we help find the solutions needed to safely improve lives and communities around the world.

    We are thrilled to enhance our product range while deepening our partnership with Ingredion.

    "We are thrilled to enhance our product range while deepening our partnership with Ingredion," said Aaron Lee, global senior vice president of Health & Nutrition for Univar Solutions. "Through this agreement, we will expand access to pharmaceutical starches and other functional excipients in the United States and Canada, helping our pharmaceutical and nutraceutical customers address formulation challenges and grow their businesses. This partnership truly underscores our commitment connecting customers to high-quality ingredients and customized market solutions, and we are optimistic that the collaboration will help enhance tableting, softgel, and encapsulation applications."

    Ingredion Pharma Solutions, part of Ingredion, a global ingredient solutions provider, produces functional ingredients, including pharmaceutical-grade starches designed to enhance formulation performance and help overcome the technical challenges experienced in various pharmaceutical and nutraceutical applications. Through the agreement, Ingredients + Specialties from Univar Solutions will distribute Ingredion's pharma portfolio and is the exclusive distributor in the United States and Canada for the Pharma starch-based excipients including UNI-PURE® F, UNI-PURE® FL, UNI-PURE® GA, and UNI-PURE® WG-220.

    "We are excited to expand our partnership with Ingredients + Specialties from Univar Solutions in the pharmaceutical starches, mannitol, and specialty excipients product space," said Joe Rogus, pharma senior sales manager – United States and Canada for Ingredion. "They are a world-class organization with an excellent track record in delivering high-value specialty products and services to pharmaceutical markets. We're confident that this collaboration will drive ingredient innovation and deliver exceptional value to our customers."

    The Ingredients + Specialties portfolio from Univar Solutions--one of the most trusted names in innovation and distribution--offers the essential specialty ingredients needed for brands and manufacturers to develop new and improved products that deliver results for their customers. The portfolio is backed by their commitment to innovation, sustainability, and quality, as well as technical support and formulation expertise to help ensure customers and suppliers are equipped to navigate the industry's rapidly changing future with confidence and creativity.

    Explore how the relationship between Ingredients + Specialties from Univar Solutions and Ingredion Pharma Solutions enhances formulation performance and addresses technical challenges.

    About Univar Solutions

    Univar Solutions is a leading global specialty chemical and ingredient distributor representing a premier portfolio from the world's leading producers. With the industry's largest private transportation fleet and technical sales force, unparalleled logistics know-how, deep market and regulatory knowledge, formulation and recipe development, and leading digital tools, the Company is well-positioned to offer tailored solutions and value-added services to a wide range of markets, industries, and applications. While fulfilling its purpose to help keep communities healthy, fed, clean, and safe, Univar Solutions is committed to helping customers and suppliers innovate and focus on Growing Together. Learn more at univarsolutions.com.

    About Ingredients + Specialties from Univar Solutions 

    Ingredients + Specialties from Univar Solutions brings the best products, people, and results to specialty customers and suppliers seeking to power modern life. By combining science, innovation, and deep expertise with a leading specialty portfolio, we help find the solutions needed to safely improve lives and communities across the globe. Learn more at univarsolutions.com.

    About Ingredion Pharma Solutions

    Ingredion Incorporated (NYSE:INGR) is a global innovative ingredient solutions provider. For Pharma & Nutraceuticals, we partner with customers seeking functional materials to enhance the performance of formulations and overcome their technical challenges. Our solutions include binders, fillers, superdisintegrants, lubricants, plasticizer, gelatine replacers for veggie softgel, emulsions for encapsulation, and parenteral APIs. We are in the continuous transformation to combine cGMP facilities, regulatory assistance, global presence, and technical support to be a trusted formulation problem-solving partner to our customers. To learn more, access ingredionpharma.com/

    Forward-Looking Statements and Information

    This communication contains "forward-looking statements" under applicable law regarding financial and operating items relating to the Company's business. Forward-looking statements generally can be identified by words such as "believes," "expects," "may," "will," "should," "could," "seeks," "intends," "plans," "estimates," "anticipates" or other comparable terms. All forward-looking statements made in this communication are qualified by this cautionary language.

    Forward-looking statements are subject to known and unknown risks and uncertainties, many of which may be beyond the Company's control, that could result in expectations not being realized or could otherwise materially and adversely affect the Company's business, financial condition, results of operations or cash flows. Although the forward-looking statements are based on what management believes to be reasonable assumptions, we caution you that the forward-looking information presented in this communication is not a guarantee of future events or results, and that actual events or results may differ materially from those made in or suggested by the forward-looking information contained in this communication. For additional information regarding factors that could affect the Company, please see the Company's most recent annual report and other financial reports, including the information set forth under the caption "Risk Factors." Any forward-looking statements represent the Company's views only as of the date of this communication and should not be relied upon as representing the Company's views as of any subsequent date, and the Company undertakes no obligation, other than as may be required by law, to update any forward-looking statement.

    "We are thrilled to enhance our product range while deepening our partnership with Ingredion,

    Univar Solutions LLC Logo (PRNewsfoto/Univar Solutions LLC)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/univar-solutions-selected-as-ingredion-pharma-solutions-distributor-in-united-states-and-canada-302696052.html

    SOURCE Univar Solutions LLC

    Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/February2026/24/c8545.html

    Get the next $INGR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $INGR

    DatePrice TargetRatingAnalyst
    11/6/2025$124.00Overweight → Equal Weight
    Barclays
    4/7/2025$145.00Buy → Neutral
    UBS
    8/9/2024$122.00 → $145.00Equal Weight → Overweight
    Barclays
    2/15/2024$122.00 → $135.00Neutral → Buy
    Goldman
    9/29/2023$120.00Outperform
    Oppenheimer
    4/14/2023$115.00Market Perform
    BMO Capital Markets
    4/13/2023$105.00 → $121.00Neutral → Buy
    UBS
    1/23/2023$105.00 → $110.00Overweight → Equal Weight
    Barclays
    More analyst ratings

    $INGR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Ingredion downgraded by Barclays with a new price target

    Barclays downgraded Ingredion from Overweight to Equal Weight and set a new price target of $124.00

    11/6/25 8:44:22 AM ET
    $INGR
    Packaged Foods
    Consumer Staples

    Ingredion downgraded by UBS with a new price target

    UBS downgraded Ingredion from Buy to Neutral and set a new price target of $145.00

    4/7/25 9:20:59 AM ET
    $INGR
    Packaged Foods
    Consumer Staples

    Ingredion upgraded by Barclays with a new price target

    Barclays upgraded Ingredion from Equal Weight to Overweight and set a new price target of $145.00 from $122.00 previously

    8/9/24 7:52:36 AM ET
    $INGR
    Packaged Foods
    Consumer Staples

    $INGR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Zallie James P. sold $1,160,605 worth of shares (9,958 units at $116.55), decreasing direct ownership by 23% to 33,011 units (SEC Form 4)

    4 - Ingredion Inc (0001046257) (Issuer)

    2/19/26 5:22:04 PM ET
    $INGR
    Packaged Foods
    Consumer Staples

    SVP, Chief Comm & Sust Officer Fernandes Larry sold $131,119 worth of shares (1,125 units at $116.55), decreasing direct ownership by 4% to 30,514 units (SEC Form 4)

    4 - Ingredion Inc (0001046257) (Issuer)

    2/19/26 5:17:20 PM ET
    $INGR
    Packaged Foods
    Consumer Staples

    President and CEO Zallie James P. covered exercise/tax liability with 7,198 shares, decreasing direct ownership by 14% to 42,969 units (SEC Form 4)

    4 - Ingredion Inc (0001046257) (Issuer)

    2/19/26 3:56:06 PM ET
    $INGR
    Packaged Foods
    Consumer Staples

    $INGR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Univar Solutions Selected as Ingredion Pharma Solutions Distributor in United States and Canada

    Pharmaceutical manufacturers will benefit from deep expertise and an extensive distribution network paired with Ingredion's functional excipientsDOWNERS GROVE, Ill., Feb. 24, 2026 /CNW/ -- Univar Solutions LLC ("Univar Solutions" or "the Company"), a leading global solutions provider to users of specialty ingredients and chemicals, today announced that its Ingredients +  Specialties from Univar Solutions division has been appointed as a distributor for Ingredion Pharma Solutions, part of Ingredion Incorporated (NYSE:INGR). The agreement includes distribution of Ingredion's global pharmaceuticals portfolio and positions the Company as the exclusive distributor of pharmaceutical starches in th

    2/24/26 12:30:00 PM ET
    $INGR
    Packaged Foods
    Consumer Staples

    Ingredion Appoints President and CEO James P. Zallie as Chairman of the Board

    WESTCHESTER, Ill., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE:INGR), a leading global provider of ingredient solutions, today announced that its board of directors has unanimously elected Jim Zallie, president and CEO, to assume the additional role of chairman of the board, effective immediately. "I am honored by the board's confidence and grateful for the opportunity to serve as Chairman. Ingredion has a strong foundation, a talented global team, and a clear strategy focused on becoming the go-to provider of texture solutions that make healthy taste better," said Jim Zallie. "I look forward to continuing to work closely with the board as we execute our growth agenda a

    2/11/26 9:00:00 AM ET
    $INGR
    Packaged Foods
    Consumer Staples

    Ingredion Incorporated Reports 2025 Fourth Quarter and Full-Year Results

    Reported and adjusted* EPS were $11.18 and $11.13 for full-year 2025, compared with $9.71 and $10.65 for full-year 2024Cash from operations was $944 million for the full-year 2025, during which the Company returned $435 million to shareholders, including $224 million of share repurchasesThe Company expects its full-year 2026 outlook for reported and adjusted EPS to be in the range of $11.00 to $11.80 WESTCHESTER, Ill., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE:INGR), a leading global provider of ingredient solutions to the food and beverage manufacturing industry, today reported its fourth quarter 2025 and full-year 2025 results. "We delivered record full-year financ

    2/3/26 6:03:00 AM ET
    $INGR
    Packaged Foods
    Consumer Staples

    $INGR
    SEC Filings

    View All

    SEC Form 10-K filed by Ingredion Incorporated

    10-K - Ingredion Inc (0001046257) (Filer)

    2/17/26 4:26:26 PM ET
    $INGR
    Packaged Foods
    Consumer Staples

    SEC Form 144 filed by Ingredion Incorporated

    144 - Ingredion Inc (0001046257) (Subject)

    2/11/26 11:17:12 AM ET
    $INGR
    Packaged Foods
    Consumer Staples

    Ingredion Incorporated filed SEC Form 8-K: Other Events

    8-K - Ingredion Inc (0001046257) (Filer)

    2/11/26 9:06:20 AM ET
    $INGR
    Packaged Foods
    Consumer Staples

    $INGR
    Leadership Updates

    Live Leadership Updates

    View All

    Ingredion Appoints President and CEO James P. Zallie as Chairman of the Board

    WESTCHESTER, Ill., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE:INGR), a leading global provider of ingredient solutions, today announced that its board of directors has unanimously elected Jim Zallie, president and CEO, to assume the additional role of chairman of the board, effective immediately. "I am honored by the board's confidence and grateful for the opportunity to serve as Chairman. Ingredion has a strong foundation, a talented global team, and a clear strategy focused on becoming the go-to provider of texture solutions that make healthy taste better," said Jim Zallie. "I look forward to continuing to work closely with the board as we execute our growth agenda a

    2/11/26 9:00:00 AM ET
    $INGR
    Packaged Foods
    Consumer Staples

    Lyric Appoints Halsey Wise as Chief Executive Officer

    Experienced Healthcare Technology Leader to Steer Next Phase of Growth Lyric, a leader in payment integrity AI and claims analytics for health plans, today announced the appointment of Halsey Wise as Chief Executive Officer, effective immediately. Mr. Wise, a member of Lyric's Board of Directors since 2022, succeeds Raj Ronanki, who has transitioned into an advisory role to support the company's continued success. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260108426844/en/Halsey Wise, CEO, Lyric "Having experienced Lyric's dynamic growth as a member of the Board, I am honored to join as CEO to propel our next chapter," sai

    1/8/26 8:00:00 AM ET
    $AZPN
    $INGR
    $CERN
    EDP Services
    Technology
    Packaged Foods
    Consumer Staples

    Gevo Strengthens Operational Leadership Amid Ongoing Growth and Succession Planning

    ENGLEWOOD, Colo., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ:GEVO), a leader in renewable fuels and chemicals, and carbon management, today announced the addition of agricultural industry veteran Greg Hanselman as executive vice president, operations and engineering. Mr. Hanselman's hire is part of Gevo's ongoing growth and succession planning, as Chris Ryan, Gevo's long-time chief operating officer, is planning to retire from the company in June of 2026. Mr. Hanselman comes to Gevo from previous roles in global agribusiness leadership as vice president of global engineering for Ingredion (NYSE:INGR), and as senior vice president of global manufacturing for Tate & Lyle, both lea

    1/5/26 9:00:00 AM ET
    $GEVO
    $INGR
    Major Chemicals
    Industrials
    Packaged Foods
    Consumer Staples

    $INGR
    Financials

    Live finance-specific insights

    View All

    Ingredion Incorporated Reports 2025 Fourth Quarter and Full-Year Results

    Reported and adjusted* EPS were $11.18 and $11.13 for full-year 2025, compared with $9.71 and $10.65 for full-year 2024Cash from operations was $944 million for the full-year 2025, during which the Company returned $435 million to shareholders, including $224 million of share repurchasesThe Company expects its full-year 2026 outlook for reported and adjusted EPS to be in the range of $11.00 to $11.80 WESTCHESTER, Ill., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE:INGR), a leading global provider of ingredient solutions to the food and beverage manufacturing industry, today reported its fourth quarter 2025 and full-year 2025 results. "We delivered record full-year financ

    2/3/26 6:03:00 AM ET
    $INGR
    Packaged Foods
    Consumer Staples

    Ingredion to Release 2025 Fourth Quarter and Full Year Financial Results On February 3, 2026

    WESTCHESTER, Ill., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE:INGR), a leading global provider of ingredient solutions to the food manufacturing industry, will release its fourth quarter and full year 2025 financial results for the period ended December 31, 2025, before the market opens Tuesday, February 3, 2026. Jim Zallie, president and chief executive officer and Jim Gray, executive vice president and chief financial officer, will host a conference call February 3 at 8 a.m. CT to discuss the Company's financial performance. The conference call and accompanying slide presentation will be webcast live at https://ir.ingredionincorporated.com/events-and-presentations. P

    1/13/26 4:03:00 PM ET
    $INGR
    Packaged Foods
    Consumer Staples

    Ingredion & GATX Roll Out Heart Health Railcar Supporting American Heart Association

    BEDFORD PARK, Ill., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE:INGR), a leading global provider of ingredient solutions for food, beverage and industrial applications, today unveiled its first-ever custom-designed railcar wrap to support the American Heart Association and promote heart health. As part of the Company's long-term sponsorship of the American Heart Association's Heart of Chicago campaign, Ingredion is introducing a custom-wrapped GATX railcar featuring the Heart Association's "Move More!" message as part of their effort to encourage Americans to be more active. The railcar promotes the importance of regular physical activity as one of the Association's Lif

    1/6/26 5:58:58 PM ET
    $GATX
    $INGR
    Transportation Services
    Consumer Discretionary
    Packaged Foods
    Consumer Staples

    $INGR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Ingredion Incorporated (Amendment)

    SC 13G/A - Ingredion Inc (0001046257) (Subject)

    2/13/24 5:06:23 PM ET
    $INGR
    Packaged Foods
    Consumer Staples

    SEC Form SC 13G/A filed by Ingredion Incorporated (Amendment)

    SC 13G/A - Ingredion Inc (0001046257) (Subject)

    2/9/23 11:22:21 AM ET
    $INGR
    Packaged Foods
    Consumer Staples

    SEC Form SC 13G/A filed by Ingredion Incorporated (Amendment)

    SC 13G/A - Ingredion Inc (0001046257) (Subject)

    2/10/22 8:17:17 AM ET
    $INGR
    Packaged Foods
    Consumer Staples